ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Kynos Therapeutics Ltd

Kynos Therapeutics Ltd is a liquidation company incorporated on 5 March 2020 with the registered office located in Bourne End, Buckinghamshire. Kynos Therapeutics Ltd was registered 5 years ago.
Status
Liquidation
Company No
12501037
Private limited company
Age
5 years
Incorporated 5 March 2020
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 4 March 2025 (7 months ago)
Next confirmation dated 4 March 2026
Due by 18 March 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Overdue
Accounts overdue by 22 days
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Small
Next accounts for period 31 December 2024
Was due on 30 September 2025 (22 days ago)
Address
Unit K Bourne End Business Park
Cores End Road
Bourne End
SL8 5AS
England
Address changed on 20 Jan 2025 (9 months ago)
Previous address was 1-3 Charter Square Sheffield S1 4HS United Kingdom
Telephone
07968 726585
Email
Unreported
Website
Unreported
People
Officers
7
Shareholders
1
Controllers (PSC)
1
Director • Director • British • Lives in UK • Born in Mar 1973
Director • British • Lives in England • Born in Mar 1957
Director • Partner • Irish • Lives in Scotland • Born in Jul 1974
Director • Consultant • French • Lives in Belgium • Born in Jun 1960
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Top Technology Ventures Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Innovations Limited
Ip2ipo Services Limited is a mutual person.
Active
Dr. Falk Pharma UK Limited
Anthony James McFadyen is a mutual person.
Active
Ieso Digital Health Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Limited
Ip2ipo Services Limited is a mutual person.
Active
Asterion Limited
Ip2ipo Services Limited is a mutual person.
Active
Fusion Ip Sheffield Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Nominees Limited
Ip2ipo Services Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£4.34M
Decreased by £83.29K (-2%)
Turnover
Unreported
Same as previous period
Employees
7
Increased by 1 (+17%)
Total Assets
£6.42M
Increased by £594.31K (+10%)
Total Liabilities
-£4.47M
Decreased by £2.71M (-38%)
Net Assets
£1.95M
Increased by £3.31M (-244%)
Debt Ratio (%)
70%
Decreased by 53.68% (-44%)
Latest Activity
Declaration of Solvency
14 Days Ago on 8 Oct 2025
Confirmation Submitted
7 Months Ago on 17 Mar 2025
Registered Address Changed
9 Months Ago on 20 Jan 2025
Charge Satisfied
9 Months Ago on 13 Jan 2025
Martin Falk (PSC) Appointed
11 Months Ago on 28 Oct 2024
Mr Anthony James Mcfadyen Appointed
11 Months Ago on 28 Oct 2024
Jonathan Rex Savidge Resigned
11 Months Ago on 28 Oct 2024
Elizabeth Ann Roper Resigned
11 Months Ago on 28 Oct 2024
Damian James Mole Resigned
11 Months Ago on 28 Oct 2024
Ip2Ipo Services Limited Resigned
11 Months Ago on 28 Oct 2024
Get Credit Report
Discover Kynos Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Declaration of solvency
Submitted on 8 Oct 2025
Resolutions
Submitted on 2 Oct 2025
Change of share class name or designation
Submitted on 11 Jun 2025
Memorandum and Articles of Association
Submitted on 9 May 2025
Resolutions
Submitted on 9 May 2025
Change of share class name or designation
Submitted on 9 May 2025
Confirmation statement made on 4 March 2025 with updates
Submitted on 17 Mar 2025
Resolutions
Submitted on 21 Jan 2025
Memorandum and Articles of Association
Submitted on 21 Jan 2025
Registered office address changed from 1-3 Charter Square Sheffield S1 4HS United Kingdom to Unit K Bourne End Business Park Cores End Road Bourne End SL8 5AS on 20 January 2025
Submitted on 20 Jan 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year